Dyslipidemia due to retroviral protease inhibitors [2] (multiple letters)

Nature Medicine

Volumn 8, Issue 4, 2002, Pages 308-309

  Kelleher, Anthony D ^a   Sewell, Andrew K ^b   Price, David A ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

DRUG BLOOD LEVEL; DYSLIPIDEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LETTER; LIPID METABOLISM; LIPOGENESIS; PRIORITY JOURNAL; PROTEINASE INHIBITION;

CELL LINE; CYSTEINE ENDOPEPTIDASES; HIV PROTEASE INHIBITORS; HUMANS; HYPERLIPIDEMIAS; KINETICS; LIPID METABOLISM; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036104601     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0402-308a     Document Type: Letter

References (0)